Astellas extends Lipitor marketing deal with Pfizer

Astellas Pharma extended its deal with Pfizer ($PFE) to market the cholesterol drug Lipitor in Japan. Under the new agreement, the companies will co-market Lipitor through November 2013, and Astellas will continue to sell it in Japan through 2021. Report